FDA Says Medtronic Facilities Must Undergo Followup Inspections

The GMP Letter
A A
The FDA hit two Medtronic device facilities with warning letters last week, citing faulty device history records and CAPA procedures.

To View This Article:

Login

Subscribe To The GMP Letter

Buy This Article Now

Add this article to your cart for $40.00